UK Foot and Ankle Thromboembolism (UK-FATE)
- PMID: 39481430
- DOI: 10.1302/0301-620X.106B11.BJJ-2024-0128.R1
UK Foot and Ankle Thromboembolism (UK-FATE)
Abstract
Aims: Venous thromboembolism (VTE) is a potential complication of foot and ankle surgery. There is a lack of agreement on contributing risk factors and chemical prophylaxis requirements. The primary outcome of this study was to analyze the 90-day incidence of symptomatic VTE and VTE-related mortality in patients undergoing foot and ankle surgery and Achilles tendon (TA) rupture. Secondary aims were to assess the variation in the provision of chemical prophylaxis and risk factors for VTE.
Methods: This was a multicentre, prospective national collaborative audit with data collection over nine months for all patients undergoing foot and ankle surgery in an operating theatre or TA rupture treatment, within participating UK hospitals. The association between VTE and thromboprophylaxis was assessed with a univariable logistic regression model. A multivariable logistic regression model was used to identify key predictors for the risk of VTE.
Results: A total of 13,569 patients were included from 68 sites. Overall, 11,363 patients were available for analysis: 44.79% were elective (n = 5,090), 42.16% were trauma excluding TA ruptures (n = 4,791), 3.50% were acute diabetic procedures (n = 398), 2.44% were TA ruptures undergoing surgery (n = 277), and 7.10% were TA ruptures treated nonoperatively (n = 807). In total, 11 chemical anticoagulants were recorded, with the most common agent being low-molecular-weight heparin (n = 6,303; 56.79%). A total of 32.71% received no chemical prophylaxis. There were 99 cases of VTE (incidence 0.87% (95% CI 0.71 to 1.06)). VTE-related mortality was 0.03% (95% CI 0.005 to 0.080). Univariable analysis showed that increased age and American Society of Anesthesiologists (ASA) grade had higher odds of VTE, as did having previous cancer, stroke, or history of VTE. On multivariable analysis, the strongest predictors for VTE were the type of foot and ankle procedure and ASA grade.
Conclusion: The 90-day incidence of symptomatic VTE and mortality related to VTE is low in foot and ankle surgery and TA management. There was notable variability in the chemical prophylaxis used. The significant risk factors associated with 90-day symptomatic VTE were TA rupture and high ASA grade.
© 2024 The British Editorial Society of Bone & Joint Surgery.
Conflict of interest statement
J. Mangwani reports support from the Leicester Hospitals Charity, related to this study. J. Mangwani reports payment or honoraria for lectures, presentations, educational events from Orthosolutions, and royalties from Meshworks, unrelated to this study. K. Malhotra reports payment or honoraria for lectures, presentations, speaker bureaus, manuscript writing or educational events from NewClip Technics, unrelated to this study. L. W. Mason reports royalties or licenses, consulting fees, and patents planned, issued or pending from Orthosolutions, unrelated to this study.
References
-
- No authors listed . Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism: NICE guideline [NG89] . National Institute for Health and Care Excellence . 2018 . https://www.nice.org.uk/guidance/ng89 ( date last accessed 3 September 2024 ).
-
- No authors listed . Venous thromboembolism in adults: quality standard [QS201] . National Institute for Health and Care Excellence . 2021 . https://www.nice.org.uk/guidance/qs201 ( date last accessed 3 September 2024 ).
-
- Mangwani J , Sheikh N , Cichero M , Williamson D . What is the evidence for chemical thromboprophylaxis in foot and ankle surgery? Systematic review of the English literature . Foot (Edinb) . 2015 ; 25 ( 3 ): 173 – 178 . 10.1016/j.foot.2014.07.007 26092561
-
- Calder JDF , Freeman R , Domeij-Arverud E , van Dijk CN , Ackermann PW . Meta-analysis and suggested guidelines for prevention of venous thromboembolism (VTE) in foot and ankle surgery . Knee Surg Sports Traumatol Arthrosc . 2016 ; 24 ( 4 ): 1409 – 1420 . 10.1007/s00167-015-3976-y 26988553
-
- Heijboer RRO , Lubberts B , Guss D , Johnson AH , Moon DK , DiGiovanni CW . Venous thromboembolism and bleeding adverse events in lower leg, ankle, and foot orthopaedic surgery with and without anticoagulants . J Bone Joint Surg Am . 2019 ; 101-A ( 6 ): 539 – 546 . 10.2106/JBJS.18.00346 30893235
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical